Bethesda, MD
Dr. Apolo is a medical oncologist with expertise in clinical and translational research in genitourinary malignancies, particularly urothelial cancer. She is an investigator on more than 35 clinical trials, authored over 100 scientific papers or chapters. The focus of her work has been to develop targeted therapies with a focus on angiogenesis, MET inhibitors and immunotherapies for the treatment of urothelial cancer and rare genitourinary tumors, and to further the understanding of the pathways driving these diseases. Her research work has the potential to improve our fundamental understanding of critical signaling pathways, advance the development of important therapeutic targets and substantially improve the outcome of patients with urothelial cancer and rare genitourinary tumors.
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Wednesday, March 9, 2022
11:25 AM – 12:40 PM
Wednesday, March 9, 2022
11:30 AM – 12:40 PM
Wednesday, March 9, 2022
12:50 PM – 3:20 PM
Wednesday, March 9, 2022
12:55 PM – 1:15 PM
Wednesday, March 9, 2022
2:35 PM – 3:20 PM
Thursday, March 10, 2022
8:45 AM – 10:05 AM
Thursday, March 10, 2022
9:37 AM – 9:44 AM
Thursday, March 10, 2022
9:44 AM – 9:50 AM
Thursday, March 10, 2022
9:50 AM – 10:30 AM